These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 22571179
1. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis. Giménez-Bachs JM, Salinas-Sánchez AS, Serrano-Oviedo L, Nam-Cha SH, Rubio-Del Campo A, Sánchez-Prieto R. Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179 [Abstract] [Full Text] [Related]
2. Expression and diagnostic implications of carbonic anhydrase IX in several tumours with predominantly clear cell morphology. Lin XY, Zhang H, Tang N, Zhang XP, Zhang W, Wang EH, Han YC. Histopathology; 2015 Apr; 66(5):685-94. PubMed ID: 25431204 [Abstract] [Full Text] [Related]
3. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray. Zerati M, Leite KR, Pontes-Junior J, Segre CC, Reis ST, Srougi M, Dall'Oglio MF. Int Braz J Urol; 2013 Apr; 39(4):484-92. PubMed ID: 24054396 [Abstract] [Full Text] [Related]
4. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E. Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812 [Abstract] [Full Text] [Related]
11. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. Phuoc NB, Ehara H, Gotoh T, Nakano M, Kamei S, Deguchi T, Hirose Y. Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901 [Abstract] [Full Text] [Related]
12. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS. Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453 [Abstract] [Full Text] [Related]
13. Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma. Pantuck AJ, Klatte T, Seligson D, Atkins M, Belldegrun A. J Clin Oncol; 2008 Jun 20; 26(18):3105-7; author reply 3107-9. PubMed ID: 18565906 [No Abstract] [Full Text] [Related]
17. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. Li G, Feng G, Gentil-Perret A, Genin C, Tostain J. J Urol; 2008 Aug 20; 180(2):510-3; discussion 513-4. PubMed ID: 18550116 [Abstract] [Full Text] [Related]
18. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Gupta R, Balzer B, Picken M, Osunkoya AO, Shet T, Alsabeh R, Luthringer D, Paner GP, Amin MB. Am J Surg Pathol; 2009 Feb 20; 33(2):241-7. PubMed ID: 18941400 [Abstract] [Full Text] [Related]
19. Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma. Jensen HK, Nordsmark M, Donskov F, Marcussen N, von der Maase H. BJU Int; 2008 Jun 20; 101 Suppl 4():41-4. PubMed ID: 18430123 [No Abstract] [Full Text] [Related]